“…Further evidence supporting the role of T cell-mediated cellular immunity in the pathogenesis of EAG is documented in recent studies, including our own, demonstrating that synthetic peptides derived from a3(IV)NC1 can induce glomerulonephritis in Wistar Kyoto (WKY) rats [28][29][30][31][32][33][34][35]. Luo et al showed that a 24-mer synthetic peptide, pCol , from the N terminus of a3(IV)NC1 was capable of inducing glomerulonephritis, although this was mild and inconsistent [29], while Wu et al showed that a 13-mer peptide, pCol (28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40), containing a T cell epitope from a3(IV)NC1, induced severe crescentic glomerulonephritis [30].…”